nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Thiotepa—sarcoma	0.162	0.458	CbGbCtD
Maraviroc—CCR5—Binding and entry of HIV virion—CXCR4—sarcoma	0.0801	0.407	CbGpPWpGaD
Maraviroc—CYP3A4—Mitoxantrone—sarcoma	0.0697	0.197	CbGbCtD
Maraviroc—CYP3A4—Vincristine—sarcoma	0.048	0.136	CbGbCtD
Maraviroc—CYP3A4—Etoposide—sarcoma	0.044	0.124	CbGbCtD
Maraviroc—CYP3A4—Doxorubicin—sarcoma	0.03	0.0847	CbGbCtD
Maraviroc—CCR5—Early Phase of HIV Life Cycle—CXCR4—sarcoma	0.0294	0.15	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCR4—sarcoma	0.0097	0.0493	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CXCR4—sarcoma	0.00776	0.0395	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—PLCG1—sarcoma	0.00691	0.0351	CbGpPWpGaD
Maraviroc—CCR5—hematopoietic system—sarcoma	0.00496	0.311	CbGeAlD
Maraviroc—CCR5—connective tissue—sarcoma	0.00478	0.299	CbGeAlD
Maraviroc—CCR5—HIV Life Cycle—CXCR4—sarcoma	0.00477	0.0243	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—NPM1—sarcoma	0.00467	0.0237	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00365	0.0186	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—sarcoma	0.00364	0.0185	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CREB1—sarcoma	0.00356	0.0181	CbGpPWpGaD
Maraviroc—CCR5—lymphoid tissue—sarcoma	0.00349	0.219	CbGeAlD
Maraviroc—CCR5—HIV Infection—CXCR4—sarcoma	0.00329	0.0168	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCR4—sarcoma	0.00308	0.0157	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00286	0.0145	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—JUN—sarcoma	0.00256	0.013	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00245	0.0125	CbGpPWpGaD
Maraviroc—CCR5—lymph node—sarcoma	0.00197	0.123	CbGeAlD
Maraviroc—CCR5—GPCR ligand binding—CXCR4—sarcoma	0.00186	0.00948	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—HRAS—sarcoma	0.00161	0.00821	CbGpPWpGaD
Maraviroc—CCR5—Disease—TLE1—sarcoma	0.00127	0.00644	CbGpPWpGaD
Maraviroc—CCR5—Disease—NPM1—sarcoma	0.00114	0.00581	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCR4—sarcoma	0.00105	0.00536	CbGpPWpGaD
Maraviroc—CCR5—Disease—ENO2—sarcoma	0.00099	0.00504	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCR4—sarcoma	0.000957	0.00487	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLE1—sarcoma	0.000888	0.00451	CbGpPWpGaD
Maraviroc—CCR5—Disease—PLCG1—sarcoma	0.00084	0.00427	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000836	0.00425	CbGpPWpGaD
Maraviroc—CCR5—Disease—CXCR4—sarcoma	0.000807	0.00411	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFC—sarcoma	0.000749	0.00381	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FLT1—sarcoma	0.000599	0.00304	CbGpPWpGaD
Maraviroc—CCR5—Disease—FOXO1—sarcoma	0.000596	0.00303	CbGpPWpGaD
Maraviroc—CCR5—Disease—PDGFRB—sarcoma	0.000595	0.00303	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLCG1—sarcoma	0.000588	0.00299	CbGpPWpGaD
Maraviroc—CCR5—Disease—PDGFRA—sarcoma	0.000586	0.00298	CbGpPWpGaD
Maraviroc—Anaemia—Etoposide—sarcoma	0.000583	0.00134	CcSEcCtD
Maraviroc—Gastrointestinal pain—Dactinomycin—sarcoma	0.000582	0.00134	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Vincristine—sarcoma	0.000579	0.00134	CcSEcCtD
Maraviroc—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000576	0.00133	CcSEcCtD
Maraviroc—Insomnia—Vincristine—sarcoma	0.000575	0.00133	CcSEcCtD
Maraviroc—Paraesthesia—Vincristine—sarcoma	0.000571	0.00132	CcSEcCtD
Maraviroc—Abdominal pain—Thiotepa—sarcoma	0.000566	0.00131	CcSEcCtD
Maraviroc—Body temperature increased—Thiotepa—sarcoma	0.000566	0.00131	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCR4—sarcoma	0.000565	0.00287	CbGpPWpGaD
Maraviroc—Leukopenia—Etoposide—sarcoma	0.000564	0.0013	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000564	0.0013	CcSEcCtD
Maraviroc—Purpura—Doxorubicin—sarcoma	0.000564	0.0013	CcSEcCtD
Maraviroc—Body temperature increased—Dactinomycin—sarcoma	0.000562	0.0013	CcSEcCtD
Maraviroc—Abdominal pain—Dactinomycin—sarcoma	0.000562	0.0013	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ATF1—sarcoma	0.000559	0.00284	CbGpPWpGaD
Maraviroc—Paraesthesia—Mitoxantrone—sarcoma	0.000556	0.00128	CcSEcCtD
Maraviroc—Loss of consciousness—Etoposide—sarcoma	0.000554	0.00128	CcSEcCtD
Maraviroc—Cerebrovascular accident—Doxorubicin—sarcoma	0.000554	0.00128	CcSEcCtD
Maraviroc—Decreased appetite—Vincristine—sarcoma	0.000552	0.00127	CcSEcCtD
Maraviroc—Cough—Etoposide—sarcoma	0.00055	0.00127	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Vincristine—sarcoma	0.000549	0.00127	CcSEcCtD
Maraviroc—Fatigue—Vincristine—sarcoma	0.000548	0.00126	CcSEcCtD
Maraviroc—Convulsion—Etoposide—sarcoma	0.000546	0.00126	CcSEcCtD
Maraviroc—Pain—Vincristine—sarcoma	0.000543	0.00125	CcSEcCtD
Maraviroc—Constipation—Vincristine—sarcoma	0.000543	0.00125	CcSEcCtD
Maraviroc—Decreased appetite—Mitoxantrone—sarcoma	0.000538	0.00124	CcSEcCtD
Maraviroc—Orthostatic hypotension—Epirubicin—sarcoma	0.000536	0.00124	CcSEcCtD
Maraviroc—Abdominal pain upper—Epirubicin—sarcoma	0.000536	0.00124	CcSEcCtD
Maraviroc—Fatigue—Mitoxantrone—sarcoma	0.000533	0.00123	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000533	0.00123	CcSEcCtD
Maraviroc—Discomfort—Etoposide—sarcoma	0.00053	0.00122	CcSEcCtD
Maraviroc—Breast disorder—Epirubicin—sarcoma	0.00053	0.00122	CcSEcCtD
Maraviroc—Pain—Mitoxantrone—sarcoma	0.000529	0.00122	CcSEcCtD
Maraviroc—Constipation—Mitoxantrone—sarcoma	0.000529	0.00122	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000529	0.00122	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000529	0.00122	CcSEcCtD
Maraviroc—Hypersensitivity—Thiotepa—sarcoma	0.000528	0.00122	CcSEcCtD
Maraviroc—Nasopharyngitis—Epirubicin—sarcoma	0.000525	0.00121	CcSEcCtD
Maraviroc—Hypersensitivity—Dactinomycin—sarcoma	0.000524	0.00121	CcSEcCtD
Maraviroc—Gastrointestinal pain—Vincristine—sarcoma	0.00052	0.0012	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000518	0.00119	CcSEcCtD
Maraviroc—Asthenia—Thiotepa—sarcoma	0.000514	0.00119	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CREB1—sarcoma	0.000513	0.00261	CbGpPWpGaD
Maraviroc—Infection—Etoposide—sarcoma	0.000511	0.00118	CcSEcCtD
Maraviroc—Abdominal distension—Epirubicin—sarcoma	0.000511	0.00118	CcSEcCtD
Maraviroc—Asthenia—Dactinomycin—sarcoma	0.00051	0.00118	CcSEcCtD
Maraviroc—Influenza—Epirubicin—sarcoma	0.000507	0.00117	CcSEcCtD
Maraviroc—Pruritus—Thiotepa—sarcoma	0.000507	0.00117	CcSEcCtD
Maraviroc—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000506	0.00117	CcSEcCtD
Maraviroc—Eosinophilia—Epirubicin—sarcoma	0.000502	0.00116	CcSEcCtD
Maraviroc—Abdominal pain—Vincristine—sarcoma	0.000502	0.00116	CcSEcCtD
Maraviroc—Body temperature increased—Vincristine—sarcoma	0.000502	0.00116	CcSEcCtD
Maraviroc—CYP3A4—hematopoietic system—sarcoma	0.0005	0.0313	CbGeAlD
Maraviroc—Skin disorder—Etoposide—sarcoma	0.0005	0.00115	CcSEcCtD
Maraviroc—Pancreatitis—Epirubicin—sarcoma	0.000497	0.00115	CcSEcCtD
Maraviroc—Abdominal pain upper—Doxorubicin—sarcoma	0.000496	0.00114	CcSEcCtD
Maraviroc—Orthostatic hypotension—Doxorubicin—sarcoma	0.000496	0.00114	CcSEcCtD
Maraviroc—Angina pectoris—Epirubicin—sarcoma	0.000494	0.00114	CcSEcCtD
Maraviroc—Breast disorder—Doxorubicin—sarcoma	0.000491	0.00113	CcSEcCtD
Maraviroc—Anorexia—Etoposide—sarcoma	0.000491	0.00113	CcSEcCtD
Maraviroc—Diarrhoea—Thiotepa—sarcoma	0.00049	0.00113	CcSEcCtD
Maraviroc—Body temperature increased—Mitoxantrone—sarcoma	0.000489	0.00113	CcSEcCtD
Maraviroc—Abdominal pain—Mitoxantrone—sarcoma	0.000489	0.00113	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000489	0.00113	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000489	0.00113	CcSEcCtD
Maraviroc—Bronchitis—Epirubicin—sarcoma	0.000488	0.00113	CcSEcCtD
Maraviroc—Diarrhoea—Dactinomycin—sarcoma	0.000487	0.00112	CcSEcCtD
Maraviroc—Nasopharyngitis—Doxorubicin—sarcoma	0.000486	0.00112	CcSEcCtD
Maraviroc—Pancytopenia—Epirubicin—sarcoma	0.000482	0.00111	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000479	0.0011	CcSEcCtD
Maraviroc—Neutropenia—Epirubicin—sarcoma	0.000474	0.00109	CcSEcCtD
Maraviroc—Dizziness—Thiotepa—sarcoma	0.000474	0.00109	CcSEcCtD
Maraviroc—Abdominal distension—Doxorubicin—sarcoma	0.000473	0.00109	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Epirubicin—sarcoma	0.000472	0.00109	CcSEcCtD
Maraviroc—Influenza—Doxorubicin—sarcoma	0.000469	0.00108	CcSEcCtD
Maraviroc—Hypersensitivity—Vincristine—sarcoma	0.000468	0.00108	CcSEcCtD
Maraviroc—Eosinophilia—Doxorubicin—sarcoma	0.000465	0.00107	CcSEcCtD
Maraviroc—Paraesthesia—Etoposide—sarcoma	0.000462	0.00107	CcSEcCtD
Maraviroc—Pancreatitis—Doxorubicin—sarcoma	0.00046	0.00106	CcSEcCtD
Maraviroc—Angina pectoris—Doxorubicin—sarcoma	0.000457	0.00105	CcSEcCtD
Maraviroc—Hypersensitivity—Mitoxantrone—sarcoma	0.000456	0.00105	CcSEcCtD
Maraviroc—Asthenia—Vincristine—sarcoma	0.000456	0.00105	CcSEcCtD
Maraviroc—Vomiting—Thiotepa—sarcoma	0.000456	0.00105	CcSEcCtD
Maraviroc—Pneumonia—Epirubicin—sarcoma	0.000455	0.00105	CcSEcCtD
Maraviroc—CCR5—Disease—KIT—sarcoma	0.000454	0.00231	CbGpPWpGaD
Maraviroc—Infestation NOS—Epirubicin—sarcoma	0.000452	0.00104	CcSEcCtD
Maraviroc—Infestation—Epirubicin—sarcoma	0.000452	0.00104	CcSEcCtD
Maraviroc—Vomiting—Dactinomycin—sarcoma	0.000452	0.00104	CcSEcCtD
Maraviroc—Rash—Thiotepa—sarcoma	0.000452	0.00104	CcSEcCtD
Maraviroc—Bronchitis—Doxorubicin—sarcoma	0.000451	0.00104	CcSEcCtD
Maraviroc—Dermatitis—Thiotepa—sarcoma	0.000451	0.00104	CcSEcCtD
Maraviroc—Headache—Thiotepa—sarcoma	0.000449	0.00104	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000448	0.00103	CcSEcCtD
Maraviroc—Rash—Dactinomycin—sarcoma	0.000448	0.00103	CcSEcCtD
Maraviroc—Decreased appetite—Etoposide—sarcoma	0.000447	0.00103	CcSEcCtD
Maraviroc—Pancytopenia—Doxorubicin—sarcoma	0.000446	0.00103	CcSEcCtD
Maraviroc—Renal failure—Epirubicin—sarcoma	0.000445	0.00103	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Etoposide—sarcoma	0.000444	0.00102	CcSEcCtD
Maraviroc—Asthenia—Mitoxantrone—sarcoma	0.000444	0.00102	CcSEcCtD
Maraviroc—Fatigue—Etoposide—sarcoma	0.000444	0.00102	CcSEcCtD
Maraviroc—Neuropathy peripheral—Epirubicin—sarcoma	0.000443	0.00102	CcSEcCtD
Maraviroc—Stomatitis—Epirubicin—sarcoma	0.000441	0.00102	CcSEcCtD
Maraviroc—Jaundice—Epirubicin—sarcoma	0.000441	0.00102	CcSEcCtD
Maraviroc—Pain—Etoposide—sarcoma	0.00044	0.00102	CcSEcCtD
Maraviroc—Constipation—Etoposide—sarcoma	0.00044	0.00102	CcSEcCtD
Maraviroc—Conjunctivitis—Epirubicin—sarcoma	0.00044	0.00101	CcSEcCtD
Maraviroc—Neutropenia—Doxorubicin—sarcoma	0.000439	0.00101	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IGF1R—sarcoma	0.000439	0.00223	CbGpPWpGaD
Maraviroc—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000436	0.00101	CcSEcCtD
Maraviroc—Diarrhoea—Vincristine—sarcoma	0.000435	0.001	CcSEcCtD
Maraviroc—CCR5—Disease—CREB1—sarcoma	0.000432	0.0022	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Epirubicin—sarcoma	0.000428	0.000987	CcSEcCtD
Maraviroc—Nausea—Thiotepa—sarcoma	0.000426	0.000982	CcSEcCtD
Maraviroc—Sinusitis—Epirubicin—sarcoma	0.000424	0.000979	CcSEcCtD
Maraviroc—Diarrhoea—Mitoxantrone—sarcoma	0.000423	0.000977	CcSEcCtD
Maraviroc—Nausea—Dactinomycin—sarcoma	0.000422	0.000974	CcSEcCtD
Maraviroc—Agranulocytosis—Epirubicin—sarcoma	0.000422	0.000974	CcSEcCtD
Maraviroc—Pneumonia—Doxorubicin—sarcoma	0.000421	0.000971	CcSEcCtD
Maraviroc—Gastrointestinal pain—Etoposide—sarcoma	0.000421	0.000971	CcSEcCtD
Maraviroc—Dizziness—Vincristine—sarcoma	0.00042	0.000969	CcSEcCtD
Maraviroc—Infestation NOS—Doxorubicin—sarcoma	0.000419	0.000965	CcSEcCtD
Maraviroc—Infestation—Doxorubicin—sarcoma	0.000419	0.000965	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FOXO1—sarcoma	0.000418	0.00212	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2—sarcoma	0.000417	0.00212	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFRB—sarcoma	0.000417	0.00212	CbGpPWpGaD
Maraviroc—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000415	0.000957	CcSEcCtD
Maraviroc—Renal failure—Doxorubicin—sarcoma	0.000411	0.000949	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PDGFRA—sarcoma	0.00041	0.00209	CbGpPWpGaD
Maraviroc—Neuropathy peripheral—Doxorubicin—sarcoma	0.00041	0.000946	CcSEcCtD
Maraviroc—Stomatitis—Doxorubicin—sarcoma	0.000408	0.000941	CcSEcCtD
Maraviroc—Jaundice—Doxorubicin—sarcoma	0.000408	0.000941	CcSEcCtD
Maraviroc—Rhinitis—Epirubicin—sarcoma	0.000407	0.000939	CcSEcCtD
Maraviroc—Abdominal pain—Etoposide—sarcoma	0.000407	0.000939	CcSEcCtD
Maraviroc—Body temperature increased—Etoposide—sarcoma	0.000407	0.000939	CcSEcCtD
Maraviroc—Conjunctivitis—Doxorubicin—sarcoma	0.000407	0.000938	CcSEcCtD
Maraviroc—Vomiting—Vincristine—sarcoma	0.000404	0.000932	CcSEcCtD
Maraviroc—Pharyngitis—Epirubicin—sarcoma	0.000403	0.00093	CcSEcCtD
Maraviroc—Urinary tract disorder—Epirubicin—sarcoma	0.000401	0.000925	CcSEcCtD
Maraviroc—Rash—Vincristine—sarcoma	0.000401	0.000924	CcSEcCtD
Maraviroc—Dermatitis—Vincristine—sarcoma	0.0004	0.000923	CcSEcCtD
Maraviroc—Connective tissue disorder—Epirubicin—sarcoma	0.000399	0.00092	CcSEcCtD
Maraviroc—Urethral disorder—Epirubicin—sarcoma	0.000398	0.000918	CcSEcCtD
Maraviroc—Headache—Vincristine—sarcoma	0.000398	0.000918	CcSEcCtD
Maraviroc—Hepatobiliary disease—Doxorubicin—sarcoma	0.000396	0.000913	CcSEcCtD
Maraviroc—Vomiting—Mitoxantrone—sarcoma	0.000393	0.000907	CcSEcCtD
Maraviroc—Sinusitis—Doxorubicin—sarcoma	0.000393	0.000906	CcSEcCtD
Maraviroc—Agranulocytosis—Doxorubicin—sarcoma	0.000391	0.000901	CcSEcCtD
Maraviroc—Rash—Mitoxantrone—sarcoma	0.00039	0.0009	CcSEcCtD
Maraviroc—Dermatitis—Mitoxantrone—sarcoma	0.00039	0.000899	CcSEcCtD
Maraviroc—Headache—Mitoxantrone—sarcoma	0.000388	0.000894	CcSEcCtD
Maraviroc—Erythema multiforme—Epirubicin—sarcoma	0.000384	0.000886	CcSEcCtD
Maraviroc—Eye disorder—Epirubicin—sarcoma	0.000379	0.000875	CcSEcCtD
Maraviroc—Hypersensitivity—Etoposide—sarcoma	0.000379	0.000875	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL2—sarcoma	0.000379	0.00193	CbGpPWpGaD
Maraviroc—Nausea—Vincristine—sarcoma	0.000377	0.000871	CcSEcCtD
Maraviroc—Cardiac disorder—Epirubicin—sarcoma	0.000377	0.000869	CcSEcCtD
Maraviroc—Rhinitis—Doxorubicin—sarcoma	0.000377	0.000869	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000375	0.00191	CbGpPWpGaD
Maraviroc—Pharyngitis—Doxorubicin—sarcoma	0.000373	0.00086	CcSEcCtD
Maraviroc—Urinary tract disorder—Doxorubicin—sarcoma	0.000371	0.000856	CcSEcCtD
Maraviroc—Asthenia—Etoposide—sarcoma	0.000369	0.000852	CcSEcCtD
Maraviroc—Connective tissue disorder—Doxorubicin—sarcoma	0.000369	0.000852	CcSEcCtD
Maraviroc—Angiopathy—Epirubicin—sarcoma	0.000368	0.00085	CcSEcCtD
Maraviroc—Urethral disorder—Doxorubicin—sarcoma	0.000368	0.00085	CcSEcCtD
Maraviroc—Nausea—Mitoxantrone—sarcoma	0.000368	0.000848	CcSEcCtD
Maraviroc—Mediastinal disorder—Epirubicin—sarcoma	0.000366	0.000844	CcSEcCtD
Maraviroc—Pruritus—Etoposide—sarcoma	0.000364	0.00084	CcSEcCtD
Maraviroc—Alopecia—Epirubicin—sarcoma	0.000359	0.000828	CcSEcCtD
Maraviroc—CCR5—Disease—MDM2—sarcoma	0.000358	0.00182	CbGpPWpGaD
Maraviroc—Mental disorder—Epirubicin—sarcoma	0.000356	0.000821	CcSEcCtD
Maraviroc—Erythema multiforme—Doxorubicin—sarcoma	0.000355	0.000819	CcSEcCtD
Maraviroc—Malnutrition—Epirubicin—sarcoma	0.000353	0.000815	CcSEcCtD
Maraviroc—Erythema—Epirubicin—sarcoma	0.000353	0.000815	CcSEcCtD
Maraviroc—Diarrhoea—Etoposide—sarcoma	0.000352	0.000812	CcSEcCtD
Maraviroc—Eye disorder—Doxorubicin—sarcoma	0.000351	0.00081	CcSEcCtD
Maraviroc—Cardiac disorder—Doxorubicin—sarcoma	0.000349	0.000804	CcSEcCtD
Maraviroc—Flatulence—Epirubicin—sarcoma	0.000348	0.000803	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KDR—sarcoma	0.000345	0.00176	CbGpPWpGaD
Maraviroc—Angiopathy—Doxorubicin—sarcoma	0.000341	0.000786	CcSEcCtD
Maraviroc—Dizziness—Etoposide—sarcoma	0.00034	0.000785	CcSEcCtD
Maraviroc—Mediastinal disorder—Doxorubicin—sarcoma	0.000339	0.000781	CcSEcCtD
Maraviroc—Alopecia—Doxorubicin—sarcoma	0.000332	0.000766	CcSEcCtD
Maraviroc—Mental disorder—Doxorubicin—sarcoma	0.000329	0.000759	CcSEcCtD
Maraviroc—Vomiting—Etoposide—sarcoma	0.000327	0.000755	CcSEcCtD
Maraviroc—Malnutrition—Doxorubicin—sarcoma	0.000327	0.000754	CcSEcCtD
Maraviroc—Erythema—Doxorubicin—sarcoma	0.000327	0.000754	CcSEcCtD
Maraviroc—Anaemia—Epirubicin—sarcoma	0.000327	0.000754	CcSEcCtD
Maraviroc—Rash—Etoposide—sarcoma	0.000325	0.000749	CcSEcCtD
Maraviroc—Dermatitis—Etoposide—sarcoma	0.000324	0.000748	CcSEcCtD
Maraviroc—Headache—Etoposide—sarcoma	0.000322	0.000744	CcSEcCtD
Maraviroc—Flatulence—Doxorubicin—sarcoma	0.000322	0.000743	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KIT—sarcoma	0.000318	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NRAS—sarcoma	0.000318	0.00162	CbGpPWpGaD
Maraviroc—Syncope—Epirubicin—sarcoma	0.000317	0.000731	CcSEcCtD
Maraviroc—Leukopenia—Epirubicin—sarcoma	0.000316	0.00073	CcSEcCtD
Maraviroc—Loss of consciousness—Epirubicin—sarcoma	0.000311	0.000717	CcSEcCtD
Maraviroc—CCR5—Disease—CTNNB1—sarcoma	0.000309	0.00157	CbGpPWpGaD
Maraviroc—Cough—Epirubicin—sarcoma	0.000308	0.000712	CcSEcCtD
Maraviroc—Convulsion—Epirubicin—sarcoma	0.000306	0.000706	CcSEcCtD
Maraviroc—Nausea—Etoposide—sarcoma	0.000306	0.000705	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CREB1—sarcoma	0.000303	0.00154	CbGpPWpGaD
Maraviroc—Anaemia—Doxorubicin—sarcoma	0.000302	0.000697	CcSEcCtD
Maraviroc—Myalgia—Epirubicin—sarcoma	0.000301	0.000694	CcSEcCtD
Maraviroc—Anxiety—Epirubicin—sarcoma	0.0003	0.000692	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000299	0.000689	CcSEcCtD
Maraviroc—Discomfort—Epirubicin—sarcoma	0.000297	0.000686	CcSEcCtD
Maraviroc—Syncope—Doxorubicin—sarcoma	0.000293	0.000677	CcSEcCtD
Maraviroc—Leukopenia—Doxorubicin—sarcoma	0.000293	0.000675	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—EGFR—sarcoma	0.00029	0.00147	CbGpPWpGaD
Maraviroc—Oedema—Epirubicin—sarcoma	0.000289	0.000665	CcSEcCtD
Maraviroc—Loss of consciousness—Doxorubicin—sarcoma	0.000287	0.000663	CcSEcCtD
Maraviroc—Infection—Epirubicin—sarcoma	0.000287	0.000661	CcSEcCtD
Maraviroc—Cough—Doxorubicin—sarcoma	0.000285	0.000658	CcSEcCtD
Maraviroc—Shock—Epirubicin—sarcoma	0.000284	0.000655	CcSEcCtD
Maraviroc—Convulsion—Doxorubicin—sarcoma	0.000283	0.000654	CcSEcCtD
Maraviroc—Nervous system disorder—Epirubicin—sarcoma	0.000283	0.000653	CcSEcCtD
Maraviroc—Skin disorder—Epirubicin—sarcoma	0.00028	0.000646	CcSEcCtD
Maraviroc—CCR5—Disease—SRC—sarcoma	0.000279	0.00142	CbGpPWpGaD
Maraviroc—Myalgia—Doxorubicin—sarcoma	0.000278	0.000642	CcSEcCtD
Maraviroc—Anxiety—Doxorubicin—sarcoma	0.000278	0.00064	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000277	0.000638	CcSEcCtD
Maraviroc—Discomfort—Doxorubicin—sarcoma	0.000275	0.000635	CcSEcCtD
Maraviroc—Anorexia—Epirubicin—sarcoma	0.000275	0.000634	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—KRAS—sarcoma	0.000274	0.00139	CbGpPWpGaD
Maraviroc—CCR5—Disease—NRAS—sarcoma	0.000268	0.00136	CbGpPWpGaD
Maraviroc—Oedema—Doxorubicin—sarcoma	0.000267	0.000616	CcSEcCtD
Maraviroc—Infection—Doxorubicin—sarcoma	0.000265	0.000612	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000263	0.000606	CcSEcCtD
Maraviroc—Shock—Doxorubicin—sarcoma	0.000263	0.000606	CcSEcCtD
Maraviroc—Nervous system disorder—Doxorubicin—sarcoma	0.000262	0.000604	CcSEcCtD
Maraviroc—Insomnia—Epirubicin—sarcoma	0.000261	0.000602	CcSEcCtD
Maraviroc—Skin disorder—Doxorubicin—sarcoma	0.000259	0.000598	CcSEcCtD
Maraviroc—CYP3A4—liver—sarcoma	0.000259	0.0162	CbGeAlD
Maraviroc—Paraesthesia—Epirubicin—sarcoma	0.000259	0.000598	CcSEcCtD
Maraviroc—Anorexia—Doxorubicin—sarcoma	0.000254	0.000587	CcSEcCtD
Maraviroc—Decreased appetite—Epirubicin—sarcoma	0.000251	0.000579	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MDM2—sarcoma	0.000251	0.00127	CbGpPWpGaD
Maraviroc—CCR5—Disease—MYC—sarcoma	0.00025	0.00127	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Epirubicin—sarcoma	0.000249	0.000575	CcSEcCtD
Maraviroc—Fatigue—Epirubicin—sarcoma	0.000249	0.000574	CcSEcCtD
Maraviroc—Pain—Epirubicin—sarcoma	0.000247	0.000569	CcSEcCtD
Maraviroc—Constipation—Epirubicin—sarcoma	0.000247	0.000569	CcSEcCtD
Maraviroc—CCR5—Disease—EGFR—sarcoma	0.000245	0.00124	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000243	0.000561	CcSEcCtD
Maraviroc—Insomnia—Doxorubicin—sarcoma	0.000241	0.000557	CcSEcCtD
Maraviroc—Paraesthesia—Doxorubicin—sarcoma	0.00024	0.000553	CcSEcCtD
Maraviroc—Gastrointestinal pain—Epirubicin—sarcoma	0.000236	0.000544	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HRAS—sarcoma	0.000233	0.00118	CbGpPWpGaD
Maraviroc—Decreased appetite—Doxorubicin—sarcoma	0.000232	0.000535	CcSEcCtD
Maraviroc—CCR5—Disease—KRAS—sarcoma	0.000231	0.00117	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00023	0.000532	CcSEcCtD
Maraviroc—Fatigue—Doxorubicin—sarcoma	0.00023	0.000531	CcSEcCtD
Maraviroc—Pain—Doxorubicin—sarcoma	0.000228	0.000527	CcSEcCtD
Maraviroc—Constipation—Doxorubicin—sarcoma	0.000228	0.000527	CcSEcCtD
Maraviroc—Abdominal pain—Epirubicin—sarcoma	0.000228	0.000526	CcSEcCtD
Maraviroc—Body temperature increased—Epirubicin—sarcoma	0.000228	0.000526	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2—sarcoma	0.000224	0.00114	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Doxorubicin—sarcoma	0.000218	0.000504	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCND1—sarcoma	0.000218	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JUN—sarcoma	0.000218	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CTNNB1—sarcoma	0.000216	0.0011	CbGpPWpGaD
Maraviroc—Hypersensitivity—Epirubicin—sarcoma	0.000213	0.00049	CcSEcCtD
Maraviroc—Abdominal pain—Doxorubicin—sarcoma	0.000211	0.000487	CcSEcCtD
Maraviroc—Body temperature increased—Doxorubicin—sarcoma	0.000211	0.000487	CcSEcCtD
Maraviroc—Asthenia—Epirubicin—sarcoma	0.000207	0.000477	CcSEcCtD
Maraviroc—Pruritus—Epirubicin—sarcoma	0.000204	0.000471	CcSEcCtD
Maraviroc—Diarrhoea—Epirubicin—sarcoma	0.000197	0.000455	CcSEcCtD
Maraviroc—Hypersensitivity—Doxorubicin—sarcoma	0.000197	0.000454	CcSEcCtD
Maraviroc—CCR5—Disease—HRAS—sarcoma	0.000196	0.000998	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SRC—sarcoma	0.000195	0.000993	CbGpPWpGaD
Maraviroc—Asthenia—Doxorubicin—sarcoma	0.000192	0.000442	CcSEcCtD
Maraviroc—Dizziness—Epirubicin—sarcoma	0.000191	0.00044	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—VEGFA—sarcoma	0.00019	0.000967	CbGpPWpGaD
Maraviroc—Pruritus—Doxorubicin—sarcoma	0.000189	0.000436	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NRAS—sarcoma	0.000188	0.000956	CbGpPWpGaD
Maraviroc—Vomiting—Epirubicin—sarcoma	0.000183	0.000423	CcSEcCtD
Maraviroc—Diarrhoea—Doxorubicin—sarcoma	0.000183	0.000421	CcSEcCtD
Maraviroc—Rash—Epirubicin—sarcoma	0.000182	0.00042	CcSEcCtD
Maraviroc—Dermatitis—Epirubicin—sarcoma	0.000182	0.000419	CcSEcCtD
Maraviroc—Headache—Epirubicin—sarcoma	0.000181	0.000417	CcSEcCtD
Maraviroc—Dizziness—Doxorubicin—sarcoma	0.000177	0.000407	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MYC—sarcoma	0.000175	0.00089	CbGpPWpGaD
Maraviroc—Nausea—Epirubicin—sarcoma	0.000171	0.000395	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EGFR—sarcoma	0.000171	0.000871	CbGpPWpGaD
Maraviroc—Vomiting—Doxorubicin—sarcoma	0.00017	0.000392	CcSEcCtD
Maraviroc—Rash—Doxorubicin—sarcoma	0.000168	0.000388	CcSEcCtD
Maraviroc—Dermatitis—Doxorubicin—sarcoma	0.000168	0.000388	CcSEcCtD
Maraviroc—Headache—Doxorubicin—sarcoma	0.000167	0.000386	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KRAS—sarcoma	0.000162	0.000822	CbGpPWpGaD
Maraviroc—Nausea—Doxorubicin—sarcoma	0.000159	0.000366	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TP53—sarcoma	0.000144	0.000731	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRAS—sarcoma	0.000137	0.000699	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO2—sarcoma	6.18e-05	0.000314	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HBA1—sarcoma	6.14e-05	0.000312	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCG1—sarcoma	5.25e-05	0.000267	CbGpPWpGaD
